New Drug Approvals Archive

New Drug Approvals: February 2005

February 17
Ammonul (sodium benzoate and sodium phenylacetate) Injection

Date of Approval: February 17, 2005

Company: Medicis

Treatment for: Hyperammonemia

Ammonul is a combination of 10% sodium phenylacetate and 10% sodium benzoate indicated as an adjunctive therapy for the treatment of acute hyperammonemia and associated encephalopathy in patients with deficiencies in enzymes of the urea cycle.

Ammonul Medicis - Treatment for Urea Cycle Disorder
 
February 22
Cardura XL (doxazosin mesylate) Extended Release Tablets

Date of Approval: February 22, 2005

Company: Pfizer Inc.

Treatment for: Benign Prostatic Hyperplasia

Cardura XL is an extended release formulation providing a controlled release of doxazosin over a 24-hour period. Cardura XL is indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH). Cardura XL is not indicated for the treatment of hypertension.

Cardura XL Pfizer Inc. - Treatment for Benign Prostatic Hyperplasia (BPH)
 

New Drug Approvals Archive

2009: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov
2008: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2007: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2006: Jan | Feb | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2005: Jan | Feb | Mar | Apr | May | Jun | Aug | Sep | Oct | Nov | Dec
2004: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2003: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2002: Jan | Feb | Jul | Aug | Oct | Nov | Dec

MedNotes
Advertisement

(web2)